Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test

The aim of this work is to present the two one-sided test (TOST) as an alternative approach to compare dissolution profiles of extended-release dosage forms. The dissolution profiles of oxycodone extended-release tablets containing 10 mg, 20 mg and 40 mg (reference and generic) were evaluated accord...

Full description

Saved in:
Bibliographic Details
Main Authors: Felipe Rebello Lourenço (Author), Daniela Dal Molim Ghisleni (Author), Rosa Noriko Yamamoto (Author), Terezinha de Jesus Andreoli Pinto (Author)
Format: Book
Published: Universidade de São Paulo, 2013-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bd49a0739f1c4ffc8d23e9dd6a87dc86
042 |a dc 
100 1 0 |a Felipe Rebello Lourenço  |e author 
700 1 0 |a Daniela Dal Molim Ghisleni  |e author 
700 1 0 |a Rosa Noriko Yamamoto  |e author 
700 1 0 |a Terezinha de Jesus Andreoli Pinto  |e author 
245 0 0 |a Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test 
260 |b Universidade de São Paulo,   |c 2013-06-01T00:00:00Z. 
500 |a 2175-9790 
500 |a 10.1590/S1984-82502013000200019 
520 |a The aim of this work is to present the two one-sided test (TOST) as an alternative approach to compare dissolution profiles of extended-release dosage forms. The dissolution profiles of oxycodone extended-release tablets containing 10 mg, 20 mg and 40 mg (reference and generic) were evaluated according to the requirements described in United States Pharmacopeia. These dissolution profiles were compared using the conventional similarity factor (f2) and the proposed TOST as an equivalence test. TOST is a simple and alternative approach to compare dissolution profiles of extended-release dosage forms. It allows us to identify the time-point (or time-points) that did not show similarity. We concluded that the two one-sided test performed at a significance level of 5% and defined as D = 10 showed results comparable to those obtained by the conventional similarity factor (f2). 
546 |a EN 
690 |a Perfil de dissolução 
690 |a Comprimidos de liberação prolongada 
690 |a Fator de semelhança 
690 |a Test uni-caudal duplo 
690 |a Teste de equivalência 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Brazilian Journal of Pharmaceutical Sciences, Vol 49, Iss 2, Pp 367-371 (2013) 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000200019&lng=en&tlng=en 
787 0 |n https://doaj.org/toc/2175-9790 
856 4 1 |u https://doaj.org/article/bd49a0739f1c4ffc8d23e9dd6a87dc86  |z Connect to this object online.